University of Groningenfounded in 1614  -  top 100 university
Close
How to find us prof. dr. E.G.E. (Elisabeth) de Vries

prof. dr. E.G.E. (Elisabeth) de Vries

Professor

No picture available
E-mail:
e.g.e.de.vries umcg.nl

Research

Research units:

51 - 77 out of 77Page size: 50
  1. Schaapveld, M. (2005). Breast cancer: patterns of care, second cancers and genetics. s.n.
  2. Zoodsma, M. (2005). Genetic susceptibility of cervical cancer. [S.n.].
  3. de Jong, M. M. (2005). Identification of genes other than the high-penetrance genes involved in colorectal and/or breast cancer susceptibility. [S.n.].
  4. Hougardy, B. M. T. (2005). Modulation of death receptor-mediated apoptosis in cervical neoplasia. s.n.
  5. Maring, J. G. (2005). New insights in pyrimidine antagonist chemotherapy: the role of pharmacokinetics and pharmacogenetics. s.n.
  6. Stokman, M. A. (2005). New options for evaluation and intervention of cancer therapy induced oral mucositis. [S.n.].
  7. Plasschaert, S. L. A. (2005). The role of ABC-transporters in childhood and adult acute lymphoblastic leukemia. [S.n.].
  8. De Vos, F. Y. F. L. (2004). Balance between desired and unwanted effects of chemotherapeutic and anti-angiogenic drugs. s.n.
  9. Reesink-Peters, N. (2004). Innovative targets for diagnostics and therapy in cervical neoplasia. [S.n.].
  10. Russo, S. (2004). The tryptophan link to psychopathology. s.n.
  11. Boonstra, R. (2003). Application of comparative genomic hybridization to identify genetic regions of relevance to tumor development or progression. s.n.
  12. Spierings, D. C. J. (2003). Death Receptors in Normal and Malignant Tissues. [S.n.].
  13. Bart, J. (2003). Function and expression of p-glycoprotein in blood-tissue barriers; translational studies. s.n.
  14. Fokkema, E. (2003). Platinum based treatment and apoptosis in lung cancer. s.n.
  15. Tol, K. M. V. (2002). New insights in diagnosis and treatment of differentiated thyroid carcinoma. s.n.
  16. Arts, H. J. G. (2002). Studies in ovarian cancer of factors related to prognosis, tumor growth and aggressiveness. s.n.
  17. Kolk, D. M. V. D. (2002). The role of drug effux pumps in acute myeloid leukemia. s.n.
  18. Gorkom, B. A. P. V. (2001). Colorectal cancer: studies on pathogenesis and prevention. s.n.
  19. Meijer, W. G. (2001). Diagnostic modalities in carcinoid tumors. s.n.
  20. Hofstra, L. S. (2001). New treatment modalities in ovarian cancer. s.n.
  21. Schröder, C. P. (2001). New ways to optimize breast cancer treatment. Rijksuniversiteit Groningen.
  22. Mourits, M. J. E. (2001). Tamoxifen effects on the female genital tract. Stichting Drukkerij C. Regenboog.
  23. Wisman, G. B. A. (2000). Telomeres and telomerase in human diseases. University of Groningen.
  24. Jong, R. S. D. (1997). Clinical studies of topoisomerase II directed anticancer drugs. s.n.
  25. Veldhuis, G. J. (1997). Hematopoietic effects of recombinant human interleukin-3 and interleukin-6. s.n.
  26. Graaf, H. D. (1997). How to fit the treatment to the breast cancer patient. s.n.
  27. Waardenburg, R. C. A. M. V. (1997). Laboratory studies of molecular genetical interventions in oncology. s.n.
Previous 1 2 Next

ID: 162081

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube